HOME  |  CAREERS  |  NEWSROOM  |  CONTACT US  

Improving patient outcomes through research

ICTD Story

GenesisCare is championing research and celebrating its passionate clinical teams and patients involved in trials this International Clinical Trials Day.

Commemorated on or near 20 May, International Clinical Trials Day marks the day James Lind began what is believed to be the world's first controlled clinical trial against the deadly disease scurvy. In 1747, he developed the theory that citrus fruits cured scurvy and the results of his trial saved the lives of thousands of sailors.

Fast forward to 2017, life expectancy has improved dramatically, attributable to advances in science, medical research and public health policies.i

GenesisCare Chief Medical Officer Dr Nathaniel Heiner said research underpinned our ability to deliver world-class treatment to our patients.

Read more ...

Dr Phuong Tran Awarded SA Camp Quality Volunteer of the Year Award

tran 2

Recently, Dr Phuong Tran, a Radiation Oncologist, with Adelaide Radiotherapy Centre, was awarded the 2016 Camp Quality Volunteer of the Year Award in SA. Camp Quality is a charity that supports young children living with cancer and their families. Members from Camp Quality, ARC Radiation Oncologists and members of the Executive Team, were on hand to see Dr Tran receive her well-deserved award, from General Manager of Camp Quality SA/NT, Heather Keele.

Dr Tran has been a Medical Volunteer with Camp Quality for 10 years and has attended over 20 camps and fun days over this time. In addition to caring for the children while on camps, she has educated volunteers about keeping the children safe and healthy during Volunteer Training Days, and provides medical advice to the organisation as required.

Read more ...

New treatment mix to improve outcomes for elderly brain tumour patients

Brain image

An international trial published in the New England Journal of Medicine has demonstrated that a new treatment mix can prolong survival for elderly patients with the most common type of brain tumour called glioblastoma.

A short course of radiotherapy, in conjunction with an oral chemotherapy drug called temozolomide, resulted in longer survival than radiotherapy alone for patients with glioblastoma aged over 64 years.

GenesisCare Newcastle Radiation Oncologist, and the study's co-principal investigator in Australia, Dr Mike Fay said the trial, which was one of the largest ever into glioblastoma, was much needed.

Read more ...

Queensland cardiologist Dr Karen Phillips visits Japan to teach cardiologists how to deliver innovative keyhole procedure

dr karen philips japan

Photo: Dr Karen Phillips (third from the right) is with Dr Yoshihiro Morino (forth from the right) and his team after their first successful Watchman implant procedure on Friday 10 March 2017.

HeartCare Partners’ cardiologist Dr Karen Phillips has just returned from a week-long teaching expedition in Japan where she instructed Japanese cardiologists to perform the Watchman implant procedure for the first time. The keyhole procedure delivers a small implant inside the heart to prevent stroke for patients with the heart condition atrial fibrillation and allows them to avoid lifelong blood thinners.

Last week, Dr Phillips taught the first procedures in Japan with multiple patients treated successfully across four hospitals in Tokyo and the northern cities of Sendai and Morioka. Dr Phillips is among several international experts from Australia, Canada and the USA who will visit Japan in 2017 to support Japanese doctors as they gain experience in the new procedure.

She has been performing the revolutionary procedure at Greenslopes Private Hospital since 2009.

Read more about Dr Karen Phillips here.

HeartCare WA cardiologists are leading Australia's largest clinical trial that aims to reduce heart attack risk

7 still

HeartCare cardiologist Dr Mark Nidorf discusses the trial with 7 News Perth

A cost-effective and readily-available medicine that's long been used to treat gout could also be used to prevent cardiovascular events in patients with stable coronary disease - a disease which develops when plaque builds up in the arteries, sometimes leading to a complete blockage and, in turn, a heart attack.

An initial pilot study led by GenesisCare's HeartCare cardiologists in Perth found that the medicine called colchicine, which can prevent inflammation, could reduce the risk of heart attack in some patients by up to 50%.

Read more ...

Genesis Logo Small.pngGenesisCare is Australia’s leading provider of radiation oncology, cardiology and sleep treatments. We exist to fill the treatment gap for the biggest disease burdens in Australia - cancer and heart care - in an environment of substantial unmet demand from an ageing population. Click here to learn more